Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: some musings

some musings

posted on Nov 08, 2006 06:33AM
After the bravado comment about basically "dozens" of companies competing for license deals....it seems more than unusual to not see new deals struck. All these companies could not have told TPL to take a hike, at the same time. For whatever reason, I think TPL/Alliasense must be the one holding back on closing the deal. Could the enormity of the whole package( the MMP portfolio) and the perceived liklihood of multiple closings have caused Tpl to reconsider sharing with PTSC. They tried once before to buy out PTSC. Is this not possible again? It just seems that everything has come to a screaching halt. No Dutton report. No updated progress on any announced initiatives. Based on the volume and price decline, I also doubt that PTSC is buying back shares recently. Does management not believe in helping supprt the stock price. Just pure speculation but I think we have some surprises coming. Can anyone honestly say that they can make sense out of the lack of announcements after the "dozens" proclamation? good luck
Share
New Message
Please login to post a reply